Thomas Fischer
- Molecular Biology
- Oncology top 10%
- Hematology top 5%
- Genetics top 10%
- Epidemiology
- Co-authors
- Stefan JacobsStefan SchulzRalf StummAndrej BaničAngela KolodziejChristian DollDaniel J. DeAngeloAndrew Spencer
- Topics
- Chronic Myeloid Leukemia Treatments (5 papers)Chronic Lymphocytic Leukemia Research (4 papers)Eosinophilic Disorders and Syndromes (4 papers)
- Cited by
- HematologyGeneticsOncology
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Thomas Fischer
33 papers receiving 912 citations
Peers
Comparison fields: 5 of 89
- Molecular Biology 400
- Oncology 279
- Hematology 229
- Genetics 144
- Epidemiology 118
Countries citing papers authored by Thomas Fischer
This map shows the geographic impact of Thomas Fischer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Fischer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Fischer more than expected).
Fields of papers citing papers by Thomas Fischer
This network shows the impact of papers produced by Thomas Fischer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Fischer. The network helps show where Thomas Fischer may publish in the future.
Co-authorship network of co-authors of Thomas Fischer
This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Fischer. A scholar is included among the top collaborators of Thomas Fischer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Fischer. Thomas Fischer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 16 | |
| 4 | 24 | |
| 5 | 10 | |
| 6 | 20 | |
| 7 | 43 | |
| 8 | 5 | |
| 9 | 116 | |
| 10 | 2 | |
| 11 | 109 | |
| 12 | 58 | |
| 13 | 74 | |
| 14 | 11 | |
| 15 | 63 | |
| 16 | 73 | |
| 17 | 2 | |
| 18 | Pharmacological profile of the FLT3-Tyrosine Kinase Inhibitor AST487 | 1 |
| 19 | 40 | |
| 20 | 12 |
About Thomas Fischer
Thomas Fischer is a scholar working on Hematology, Oncology and Rheumatology, having authored 33 papers that have together received 931 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Eosinophilic Disorders and Syndromes (4 papers). The work is most often cited by research in Hematology (229 citations), Genetics (144 citations) and Oncology (279 citations). Thomas Fischer has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Stefan Jacobs, Stefan Schulz, Ralf Stumm, Andrej Banič, Angela Kolodziej, Christian Doll, Daniel J. DeAngelo, Andrew Spencer, Oliver G. Ottmann and Kapil N. Bhalla. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.